1Division of Bone Marrow Transplantation, Stanford University Medical Center, Stanford, California; 2Division of
Bone Marrow Transplantation, Barbara A. Karmanos Cancer Center, Detroit, Michigan; 3Division of Biostatistics,
Duke University Medical Center, Durham, North Carolina; 4Director Clinical Oncology Research, Memorial Healthcare
Your doctor examines the test results, gives you a
serious look, and says, "You may have cancer."
Perhaps no other words strike greater fear in a patient
Avastin, Erbitux, Gleevec …
The new wonder drugs might make you think we’re finally beating this dreaded scourge. We’re not. Here’s how to turn the fight around.
MONDAY, Sept. 12
(HealthDay News) -- High
doses of vitamin C administered intravenously can
fight cancer -- at least in the laboratory, researchers report.
Scientists have found that high intravenous doses of vitamin C kills cancer cells. The ascorbate
dose has to be very high, too high to be taken orally, hence the intravenous administration. Some
recent trials showed orally administered vitamin C had no effect on cancer cells, so the researchers decided to see what would happen if they injected the ascorbate straight into the bloodstream.
Cancer researchers are learning that a problem once considered minor in the fight against cancer -- false-positive test results -- in fact have long-term psychological and economic consequences. And researchers say these costs need to be considered before a patient undergoes screening.